MarketPulse
securities fraudclass action lawsuittrading suspension

NASDAQ-Listed Charming Medical Faces Class Action Over Stock Promotion Scheme

BenzingaBenzinga
|||1 min read
Key Takeaway

Class action filed against Charming Medical for alleged stock price manipulation through coordinated social media promotion. Trading suspended pending SEC investigation.

NASDAQ-Listed Charming Medical Faces Class Action Over Stock Promotion Scheme
$MCTAnegative

A class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) following a Securities and Exchange Commission investigation into allegations that financial advisors engaged in coordinated social media promotion to artificially inflate the company's stock price. The SEC subsequently suspended trading in the company's shares pending the outcome of its inquiry.

The litigation, initiated by the DJS Law Group, covers transactions during a period spanning from October 21, 2025 through November 12, 2025. The case addresses investor claims related to securities law violations stemming from the alleged promotional activities.

Shareholders who transacted in MCTA securities during the relevant period have until February 17, 2026 to request inclusion in the class action. The case represents a continuing regulatory focus on market manipulation through digital platforms and unauthorized promotional activities in equity securities.

Topics

securities fraudclass action lawsuittrading suspensionSEC investigationstock manipulationsocial media promotion

Source: Benzinga

Back to newsPublished Feb 13

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

Immutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit

Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.

IMMP